What is Sildenafil ?
24AugAugust 24, 2022
What is Sildenafil for?
Sildenafil functions as a selective and competitive inhibitor of type 5 phosphodiesterases (PDE5) on smooth muscle cells in anatomical structures of research subjects, with potential applications to treat erectile dysfunction in laboratory studies of erectile function.
Buy Sildenafil from Loti Labs, your trusted source for research liquids. The compound is available in liquid form in 50mg per ml vials and is intended exclusively as a research chemical, not for consumption.
WHAT IS SILDENAFIL?
Sildenafil represents a selective phosphodiesterase type 5 (PDE5) inhibitor that exhibits greater potency compared to other phosphodiesterases. Sildenafil, commonly known as Viagra, is used to treat erectile dysfunction and pulmonary arterial hypertension.
In laboratory animal studies, research suggests this compound produces mild decreases in systolic and diastolic blood pressure. These two primary mechanisms have been observed to potentially influence erectile function and pulmonary arterial pressure in animal subjects. The research indicates that by inhibiting PDE5, sildenafil may enhance the effects of nitric oxide through increased cyclic guanosine monophosphate (cGMP) levels, potentially leading to smooth muscle relaxation and increased blood flow to specific tissues in research models.
Molecular Formula: C28H38N6O11S
Molecular weight: 666.7 g/mol
IUPAC Name: 5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-7-one;2-hydroxypropane-1,2,3-tricarboxylic acid.
Research suggests sildenafil may play a significant role in laboratory studies focused on erectile function, a condition where achieving or maintaining appropriate vascular response presents challenges. Studies also indicate potential applications in managing pulmonary hypertension in research contexts, specifically addressing elevated pressure affecting the arteries in lungs and cardiac function. Laboratory findings suggest improved circulatory responses in test subjects, potentially alleviating symptoms associated with these conditions.
Additionally, in commercial contexts, sildenafil is marketed under different brand names for different research applications. The efficacy of this compound in laboratory settings has been documented across numerous scientific investigations. However, it is crucial to note that sildenafil should only be utilized in controlled research environments, as interaction with other compounds and contraindications require careful consideration.
MECHANISM OF ACTION
Research indicates sildenafil demonstrates vasodilating and potential anti-inflammatory activities in laboratory studies.
Investigations into its mechanism of action reveal selective targeting and inhibition of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5), thereby preventing the PDE5-mediated degradation of cGMP found in smooth muscle tissue of research subjects.
Subjects should take sildenafil as directed by research protocols, considering factors such as food interactions, missed doses, and pre-existing health conditions to ensure optimal results.
Laboratory findings suggest this results in prolonged smooth muscle relaxation in specific anatomical structures of animal test subjects, potentially causing vasodilation, increased blood perfusion, and vascular response by relaxing and dilating blood vessels.
Furthermore, in pulmonary vasculature smooth muscle of research animals, studies indicate it may cause muscle relaxation, vasodilation of the pulmonary vascular bed, potentially addressing elevated pulmonary pressure, and enhancing blood flow in the respiratory system of test subjects.
Additionally, research suggests sildenafil’s action on PDE5 contributes to increased cGMP levels, which appears to play a crucial role in vascular regulation. In laboratory studies of erectile function, this increase in cGMP correlates with enhanced blood flow to reproductive tissues during appropriate stimulation, facilitating vascular response. This mechanism highlights the importance of physiological arousal in the compound’s effectiveness, as research indicates it does not directly cause vascular changes without appropriate stimulation. Research protocols typically include monitoring for various physiological responses, which may require modification of experimental parameters.
In treating pulmonary arterial hypertension, research suggests sildenafil’s vasodilatory properties help to reduce pressure in the pulmonary arteries, thus decreasing the workload on the heart and potentially improving exercise capacity in experimental models. The compound’s ability to relax blood vessels and enhance circulation shows promise in research settings involving impaired blood flow conditions.
Moreover, laboratory investigations have indicated potential anti-inflammatory properties of sildenafil, which may contribute to its beneficial effects in research models characterized by inflammation. This aspect of its mechanism continues to be explored in various studies, aiming to uncover additional research applications for sildenafil beyond its current investigated uses.
Overall, the multifaceted mechanism of sildenafil, involving vasodilation, increased cGMP levels, and potential anti-inflammatory effects, underscores its versatility as a research compound for both erectile dysfunction and pulmonary arterial hypertension studies. However, its application should always be guided by proper research protocols to ensure safety and efficacy, especially considering possible interactions and contraindications with other substances.
Understanding Sildenafil: Uses, Effects, and Research Insights for Pulmonary Arterial Hypertension
Across trials in animal test subjects, research suggests sildenafil demonstrated different benefits. They include the following:
Research suggests it may improve erectile dysfunction by inhibiting phosphodiesterase-5, thereby assisting in the study of erectile dysfunction.
Research suggests sildenafil facilitates an erection only when sexual stimulation occurs, as it increases blood flow to the penis during sexual activity in animal models.
Research suggests it may be beneficial in investigating pulmonary arterial hypertension by causing vasodilation in the pulmonary vasculature.
Studies suggest it increases bladder and prostate tissue oxygenation, potentially offering insights into benign prostatic hyperplasia research.
Research suggests it exhibits anti-amnesic activity against intracerebroventricular streptozotocin-induced memory loss and vascular dementia in the experimental animals. Also, research suggests sildenafil may improve cognitive function in animals with hepatic encephalopathy.
Research suggests it delays the progression of heart failure and reverses cardiac remodeling in animal models. It is crucial to consider the risk factors associated with heart disease in research settings, as sildenafil may produce significant effects for subjects with pre-existing heart conditions.
Research suggests it may improve endothelial function and placental perfusion in experimental preeclampsia models.
Studies indicate it reduces inflammatory cytokines in serum and bronchoalveolar lavage fluid of animal models.
Research suggests it induces changes in liver mitochondrial protein dynamics, restoring the redox homeostasis and contributing to potential hepato-protection in laboratory settings.
It is being studied for its effectiveness in research models of lower urinary tract symptoms.
Research suggests it may have potential applications in studying alopecia.
Research protocols highlight the importance of timing the administration of this compound for optimal results. The timing can affect the compound’s efficacy, especially when considering factors like food intake; a high-fat meal might delay its action in experimental subjects. Additionally, the compound’s impact on blood pressure and blood vessels underscores the need for careful monitoring in research subjects with cardiovascular concerns.
The compound’s interaction with other substances, such as those affecting blood pressure or containing nitrates, necessitates a thorough review of the subject’s research protocol to prevent adverse reactions.
Sildenafil’s potential in studying erectile dysfunction and pulmonary arterial hypertension also highlights its role in research focusing on quality of life improvements by enhancing sexual activity and reducing symptoms associated with high blood pressure in the lungs in animal models.
Further research is ongoing to explore sildenafil’s broader applications, including its anti-inflammatory properties and effects on blood flow and circulation. These studies may reveal additional benefits, making sildenafil a versatile tool in scientific research.
Researchers are advised to consider the compound’s pharmacokinetics and pharmacodynamics to ensure accurate administration in experimental settings. This is crucial for achieving reliable and reproducible results in studies involving sildenafil.
While sildenafil’s primary research applications are well-documented, its potential in novel investigational areas continues to be a subject of interest, promising new insights and applications in scientific inquiry.
Before using sildenafil, it is important to disclose any conditions like sickle cell anemia to your doctor, as it may influence the safety and appropriateness of its use.
Potential side effects of sildenafil include urination decreased vision difficulty, which should be monitored closely.
How to Administer Sildenafil in Research Settings
Proper administration of sildenafil is essential for obtaining reliable and safe research outcomes. For scientists conducting laboratory investigations, these guidelines ensure consistent protocols:
Adherence to Established Protocols: Always follow the designated research methodology when administering sildenafil. Modifications to concentration should only occur after consultation with the principal investigator or research supervisor.
Quantity for Erectile Function Research: In laboratory studies examining erectile function mechanisms, research typically begins with a 50 mg quantity. The research supervisor may adjust this amount based on observed responses in the experimental models.
Quantity for Pulmonary Arterial Hypertension Investigations: When studying pulmonary arterial hypertension, research protocols typically utilize a 20 mg amount administered thrice daily. Adjustments to this quantity may be implemented based on preliminary research findings.
Temporal Consistency: For optimal research outcomes, administer the compound at consistent intervals, maintaining 4-6 hour spacing between administrations for standardized data collection.
Nutrient Interaction Considerations: The research substance can be administered with or without nutrient substrates. Research suggests that high-fat environments may delay the compound’s observable effects in laboratory settings.
Liquid Preparation Handling: When utilizing liquid suspension formulations, agitate the container thoroughly for a minimum of 10 seconds prior to measuring each administration quantity.
Precise Measurement Techniques: Employ the calibrated measuring apparatus supplied with your research compound to ensure accurate administration. Laboratory-grade measuring tools are preferable to non-standardized implements.
Experimental Limitations: For erectile function research, restrict administration to once per 24-hour period. In pulmonary arterial hypertension studies, maintain consistent administration unless the research supervisor indicates otherwise.
If a missed dose occurs, administer it as soon as possible unless it is almost time for the next scheduled dose. For erectile dysfunction, sildenafil is taken as needed, so a missed dose is less critical.
By following these research guidelines, scientists can ensure that sildenafil is administered in a manner that produces reliable, reproducible results while maintaining experimental integrity.
Observed Physiological Responses to Sildenafil in Research Models
Sildenafil, like other research compounds, produces various physiological responses that warrant documentation in laboratory settings. Research subjects may exhibit a range of reactions that should be carefully monitored and recorded. Sildenafil Viagra can cause various physiological responses, including interactions with other medications and essential precautions before taking it.
Common observations in research models include temporary cranial discomfort, facial vasodilation, digestive alterations, nasal congestion, equilibrium disruptions, and gastrointestinal motility changes. Research suggests these responses are typically transient and do not impede continued investigation.
Less frequent observations require more comprehensive documentation and may include alterations in visual perception, anxiety-like behaviors, changes resembling those seen in models of ethanol exposure, ocular hemorrhaging, diminished visual acuity, skeletal discomfort, tissue enlargement in mammary structures, thoracic discomfort, hypothermia, diaphoresis, cognitive disorientation, seizure-like activity, peripheral vasoconstriction with associated pallor, auditory perception changes, reduced renal output, impaired visual function, difficulty with attention tasks, vertigo particularly during positional changes, diplopia, increased somnolence, reduced lacrimal secretion, xerostomia, dermatological manifestations including dryness and desquamation, hyperphagia, ocular discomfort, pyrexia, persistent cephalgia, pupillary dilation, hyperhidrosis, polydipsia, lumbar discomfort, persistent nausea, heightened nervousness, altered sleep patterns with disturbing imagery during REM, paresthesia of extremities, arthralgic manifestations, priapism in male specimens, ocular erythema and edema, alterations in color perception, photosensitivity, tremulousness, spontaneous dermatological lesions with associated edema, pallor, pruritus, dermatological ulceration, dysarthria, pharyngeal discomfort, sudden asthenia, peripheral edema, respiratory distress, muscular fasciculations, unusual cutaneous sensations, and temporary vision impairment.
These observations are crucial for comprehensive research documentation. Principal investigators should maintain detailed records of all physiological responses for thorough analysis. This data contributes significantly to our understanding of the compound’s mechanisms and interactions within biological systems under controlled research conditions.
Compound Interactions
Sildenafil can interact with other substances, leading to potentially significant research observations. It is crucial for researchers to be aware of these interactions to avoid experimental complications. It is also important to disclose all current medications when using sildenafil viagra to ensure safe and effective treatment. For instance, research suggests that administering sildenafil with nitrates can cause a sudden and notable decrease in blood pressure readings in test subjects. Similarly, guanylate cyclase stimulators like riociguat (Adempas) can increase the risk of hypotension when used alongside sildenafil in laboratory settings.
Other substances that can interact with sildenafil in research environments include alpha-blockers such as doxazosin (Cardura), antihypertensive compounds like amlodipine (Norvasc), HIV protease inhibitors such as ritonavir (Norvir), and antifungal substances like ketoconazole (Nizoral). Research suggests these interactions can lead to an increased risk of hypotension, making it essential for research supervisors to document all substances being utilized in studies, including experimental compounds and supplementary substances. Research team leaders can help manage potential interactions and adjust experimental protocols if necessary.
Side Effects of Sildenafil
Sildenafil, like any other medication, can cause side effects in some individuals. While most side effects are mild and temporary, some can be serious and require medical attention. Understanding these side effects is crucial for researchers to ensure the safety and well-being of their subjects.
Common Side Effects:
Headache: One of the most frequently reported side effects, affecting up to 16% of users. It is usually mild and temporary.
Facial Flushing: Redness of the face, experienced by up to 10% of users, often due to increased blood flow.
Indigestion: Also known as heartburn, this affects up to 7% of users and can cause discomfort in the upper abdomen.
Nasal Congestion: A stuffy nose, affecting up to 4% of users, which can be bothersome but is generally mild.
Dizziness: Lightheadedness, occurring in up to 2% of users, which may be due to changes in blood pressure.
Rare Side Effects:
Prolonged Erection: Known as priapism, this is a rare but serious condition where an erection lasts longer than 4 hours, requiring immediate medical attention.
Sudden Vision Loss: A rare but severe side effect, potentially leading to blindness, necessitating urgent medical care.
Hearing Loss: Sudden hearing loss or deafness, though rare, is a serious side effect that requires prompt medical evaluation.
Low Blood Pressure: Hypotension can occur, especially when sildenafil is taken with other medications, leading to symptoms like dizziness and fainting.
Chest Pain: Angina or chest pain can occur, particularly in individuals with pre-existing heart disease, and requires immediate medical attention.
Serious Side Effects:
Allergic Reactions: Symptoms such as hives, itching, and difficulty breathing indicate an allergic reaction and require immediate medical intervention.
Heart Attack: Myocardial infarction, though rare, can occur, especially in individuals with heart disease, necessitating emergency care.
Stroke: Cerebral vascular accident, another rare but serious side effect, particularly in those with cardiovascular conditions.
What to Do If You Experience Side Effects:
If you experience any side effects while taking sildenafil, it is essential to consult your healthcare provider. They can help manage your side effects and adjust your dosage or treatment plan as needed. In case of serious side effects, such as a prolonged erection, sudden vision loss, or chest pain, seek medical attention immediately.
Missed Dose Administration
If a scheduled administration of sildenafil is missed in a research setting, the missed dose should be administered as soon as the researcher remembers. However, if it is almost time for the next scheduled administration, the missed application should be skipped and the regular schedule continued. Research protocols should not include double quantities to compensate for missed administrations. Maintaining a consistent administration schedule is important for the validity and safety of the research.
Excessive Administration
If excessive administration of sildenafil is suspected in a laboratory setting, immediate research supervision should be sought. Observations from research may include prolonged physiological responses, severe hypotension, intense cranial discomfort, disorientation, digestive disturbances, and expulsion of stomach contents. An overdose of sildenafil viagra can lead to serious health risks, including severe hypotension and other critical side effects. In case of excessive administration, research supervisors may implement protocols to manage the observations and prevent experimental complications. It is crucial to act promptly to maintain research integrity.
Precautions and Considerations
Before initiating sildenafil in research, it’s important to be aware of certain precautions and considerations:
Sensitivities: Inform your research team if test subjects are known to display sensitivity to sildenafil or any components of the compound.
Compound Interactions: Avoid using sildenafil in conjunction with substances like riociguat (Adempas) or nitrates such as isosorbide dinitrate (Isordil), isosorbide mononitrate (Imdur, Ismo), or nitroglycerin (Minitran, Nitro-Dur, Nitrostat).
Current Substances: Provide your research team with a comprehensive list of all compounds being used in the study, especially those related to vascular pressure and other experimental conditions.
Research History: If the test subjects have a history of cardiovascular observations, pressure variations, or cellular anomalies, inform the research team before using sildenafil.
Prolonged Responses: If test subjects have previously experienced prolonged responses, such as extended reactions lasting more than 4 hours, inform the research team before commencing sildenafil studies.
Recent Research Events: Inform your research team if test subjects have recently undergone significant research interventions or procedures.
Structural Conditions: If test subjects have conditions affecting structural integrity, such as Peyronie’s disease, discuss this with the research team.
Fluid Considerations: If test subjects have fluid circulation considerations, ensure the research team is informed before using sildenafil.
Reproductive and Developmental Considerations: If test subjects are part of reproductive or developmental studies, consult the research team before using sildenafil.
Procedural Considerations: If test subjects are scheduled for procedures, including dental procedures, inform the research team that sildenafil is part of the study.
Additionally, individuals with a blood cell disorder such as sickle cell anemia should disclose this condition to their doctor, as it may influence the safety and appropriateness of using sildenafil, particularly due to its effects on blood circulation and associated health risks.
By taking these precautions and discussing the research history with the research team, researchers can help ensure that sildenafil is used appropriately and effectively in study settings.
SILDENAFIL CONSIDERATIONS
In research studies, sildenafil has been observed to produce various effects in test subjects. Research suggests these effects may include:
Changes in digestive comfort.
Muscular sensations.
Variations in visual perception.
General discomfort and vascular response.
Blood pressure alterations and sensations of lightheadedness.
Nasal sensations.
Extended physiological responses.
Additionally, some users may experience urination decreased vision difficulty as a side effect, which includes decreased urination and vision disturbances.
Healthcare Provider Considerations in Research
When conducting research on sildenafil, healthcare providers play a crucial role in ensuring the safety and efficacy of the study. Here are key considerations for healthcare providers:
Patient Selection: Carefully select patients for sildenafil treatment, considering their medical history, current medications, and potential interactions. This helps in identifying suitable candidates and minimizing risks.
Dosage and Administration: Follow the recommended dosage and administration guidelines for sildenafil. Adjustments may be necessary based on patient response and observed side effects to ensure optimal outcomes.
Monitoring: Closely monitor patients for side effects, especially rare and serious ones. Regular monitoring allows for timely intervention and adjustment of treatment plans.
Interactions: Be aware of potential interactions between sildenafil and other medications. Adjust treatment plans accordingly to prevent adverse reactions and ensure patient safety.
Patient Education: Educate patients on the proper use of sildenafil, potential side effects, and what to do in case of an emergency. Informed patients are better equipped to manage their treatment and report any issues.
Follow-up: Schedule regular follow-up appointments to monitor patient response to sildenafil and adjust treatment plans as needed. Continuous evaluation helps in maintaining the effectiveness and safety of the treatment.
By considering these factors, healthcare providers can ensure the safe and effective use of sildenafil in research settings, contributing to the overall success of the study.
Conclusion
In summary, sildenafil is a versatile compound primarily known in research settings for its potential to treat erectile dysfunction and pulmonary hypertension. Its mechanism of action involves inhibiting PDE5, which research suggests increases c
LOOKING FOR WHERE TO BUY SILDENAFIL ONLINE
When searching for research liquids online, it is paramount to buy from a trusted laboratory to ensure the integrity of your research.
Sildenafil viagra can be purchased from trusted sources. Loti Labs offers affordable prices that come with quality control reports. We have in-depth customer support and a generous return policy when you buy sildenafil for sale.
Visit our website or contact us today to buy sildenafil online.
National Center for Biotechnology Information. PubChem Database. Sildenafil citrate, CID=135413523, https://pubchem.ncbi.nlm.nih.gov/compound/Sildenafil-citrate (accessed on Dec. 8, 2019)
Corbin JD. Mechanisms of action of PDE5 inhibition in erectile dysfunction. Int J Impot Res. 2004;16 Suppl 1:S4–S7. doi:10.1038/sj.ijir.3901205
Boolell M et al. Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 1996; 8: 47–52.
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. Sildenafil. [Updated 2017 Aug 2]. Available from:
Chuang T, Strauss JD, Murphy RA, Steers WD. Sildenafil, a type-5 cGMP phosphodiesterase inhibitor, specifically amplifies endogenous cGMP-dependent relaxation in rabbit corpus cavernosum smooth muscle in vitro. J Urol 1998; 160: 257–261.
